Tag: GlaxoSmithKline

February 11, 2021

10 Top Pharma Companies by Revenue

Here's a breakdown of the top pharma companies by revenue in 2019, according to information from research firm GlobalData.
January 13, 2020

23andMe Working on New Drug Based on Users’ Genetics

23andMe is teaming up with Spanish drugmaker Almirall to develop an antibody that treats certain inflammatory diseases using customer data.
January 6, 2020

Pharma Outlook 2020: Oncology Commands Sector Growth

At the dawn of a new year, INN offers a preview of potential developments in the pharmaceutical market throughout 2020.
October 2, 2019

GlaxoSmithKline Files NDA for Inhaler to Treat Asthma

The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
September 10, 2019

VBI Vaccines Announces Phase 2a Clinical Evaluation of VBI-1901

VBI Vaccines (NASDAQ:VBI) has announced a collaboration with GlaxoSmithKline (NYSE:GSK) to evaluate VBI’s VBI-1901 with GSK’s AS01 adjuvant system. As...
August 29, 2019

AstraZeneca’s Lupus Drug Finally Meets Endpoints in Phase 3 Trial

The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
August 15, 2019

10 Top Drug Sales to Watch Until 2024

Drug sales are expected to top US$1 trillion by 2024, even though a number of patents are set to expire...